This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Totpal, K. Articles by Aggarwal, B. B. Search for Related Content PubMed PubMed Citation Articles by Totpal, K. Articles by Aggarwal, B. B.

Phosphatase Inhibitors Modulate the Growth-regulatory Effects of Human Tumor Necrosis Factor on Tumor and Normal Cells¹

Cytokine Research Laboratory, Department of Clinical Immunology and Biological Therapy, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [K. T., B. B. A.] and Department of Microbiology and Biochemistry, School of Dental Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261 [S. A.]

Tumor necrosis factor (TNF-) has been shown to inhibit the growth of tumor cells and stimulate the growth of certain normal cells in vitro. The mechanism by which TNF exerts its cell growth-regulatory effects is not known. In this report, we investigated the effects of phosphatase inhibitors on the cell growth-inhibitory effects of TNF on L-929, a highly sensitive murine connective tissue tumor cell line, and on the growth-stimulatory effects of TNF on normal human fibroblasts. The antiproliferative effects of TNF on L-929 cells were inhibited by orthovanadate, an inhibitor of phosphotyrosine phosphatases, in a dose-dependent manner. Okadaic acid, which is a specific inhibitor of phosphoserine- and phosphothreonine-specific phosphatases, also blocked the growth-inhibitory effects of TNF, suggesting that TNF may function through the activation of certain phosphatases. These inhibitors had no effect on TNF receptors. Addition of phosphatase inhibitor, even 12 h after the treatment of cells with TNF, was sufficient to block the antiproliferative effects of the cytokine, suggesting that the inhibitor is acting at a late event in the pathway of action of TNF. Cells were protected by orthovanadate from the cytotoxic effects of TNF even in the presence of actinomycin D or cycloheximide, thus indicating the lack of a requirement for de novo protein synthesis. Orthovanadate altered the cell morphology from flat spindle shapes to rounded ones. Besides anticellular effects, a phosphatase inhibitor also suppressed the proliferative effects of TNF on human fibroblasts. These results thus suggest that phosphatases may be needed for both proliferative and antiproliferative effects of this cytokine. This is the first report to suggest that phosphatases play a role in the growth-regulatory action of TNF.

¹ Supported in part by new program development funds from the University of Texas M. D. Anderson Cancer Center.

² To whom requests for reprints should be addressed, at Cytokine Research Laboratory, CIBT no. 41, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston TX 77030.

Received 9/27/91. Accepted 2/25/92.

This article has been cited by other articles:

				M. Halle, Y.-C. Liu, S. Hardy, J.-F. Theberge, C. Blanchetot, A. Bourdeau, T.-C. Meng, and M. L. Tremblay Caspase-3 Regulates Catalytic Activity and Scaffolding Functions of the Protein Tyrosine Phosphatase PEST, a Novel Modulator of the Apoptotic Response Mol. Cell. Biol., February 1, 2007; 27(3): 1172 - 1190. [Abstract] [Full Text] [PDF]

				J. Yoshida, T. Ishibashi, and M. Nishio Growth-inhibitory Effect of a Streptococcal Antitumor Glycoprotein on Human Epidermoid Carcinoma A431 Cells: Involvement of Dephosphorylation of Epidermal Growth Factor Receptor Cancer Res., August 1, 2001; 61(16): 6151 - 6157. [Abstract] [Full Text] [PDF]

				K. Mahboubi, W. Young, and N. R. Ferreri Tyrosine Phosphatase-Dependent/Tyrosine Kinase-Independent Induction of Nuclear Factor-kappa B by Tumor Necrosis Factor-alpha : Effects on Prostaglandin Endoperoxide Synthase-2 mRNA Accumulation J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 862 - 868. [Abstract] [Full Text]

				M. W. Marino, J. D. Dunbar, L.-W. Wu, J. R. Ngaiza, H.-M. Han, D. Guo, M. Matsushita, A. C. Nairn, Y. Zhang, R. Kolesnick, et al. Inhibition of Tumor Necrosis Factor Signal Transduction in Endothelial Cells by Dimethylaminopurine J. Biol. Chem., November 8, 1996; 271(45): 28624 - 28629. [Abstract] [Full Text] [PDF]

				R. Beyaert, B. Vanhaesebroeck, W. Declercq, J. Van Lint, P. Vandenabeele, P. Agostinis, J. R. Vandenheede, and W. Fiers Casein Kinase-1 Phosphorylates the p75 Tumor Necrosis Factor Receptor and Negatively Regulates Tumor Necrosis Factor Signaling for Apoptosis J. Biol. Chem., October 6, 1995; 270(40): 23293 - 23299. [Abstract] [Full Text] [PDF]

				H. Kanety, R. Feinstein, M. Z. Papa, R. Hemi, and A. Karasik Tumor Necrosis Factor alpha-induced Phosphorylation of Insulin Receptor Substrate-1 (IRS-1) J. Biol. Chem., October 6, 1995; 270(40): 23780 - 23784. [Abstract] [Full Text] [PDF]

				S. Singh and B. B. Aggarwal Protein-tyrosine Phosphatase Inhibitors Block Tumor Necrosis Factor-dependent Activation of the Nuclear Transcription Factor NF-[IMAGE]B J. Biol. Chem., May 5, 1995; 270(18): 10631 - 10639. [Abstract] [Full Text] [PDF]